Compared to conventional treatment, Tongxinluo significantly improves the efficacy rate, neurological deficit scores, Barthel index scores, levels of hs-CRP, TNF-α, IL-6, blood lipids, and hemorheological parameters in stroke patients, with no serious adverse reactions observed during the treatment period. This evidence concerns the gene IL6 and stroke disorder.